← Leaderboards
Adriana Baez
University Of Puerto Rico Med Sciences
$120,680
Attributed
$120,680
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$120,680 · 3
By mechanism
S06$120,680 · 1
P20$0 · 1
U54$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Puerto Rico Med Sciences
Same institution · by research overlap
- Reynold Eugenio Lopez-Enriquez$3,090,813
- Carmen D Zorrilla$38,225,066
- Emma Fernandez-Repollet$13,596,350
- Walter R Frontera$17,918,756
- Carlos A. Luciano$3,466,026
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerPuerto RicanPuerto RicoHead /Neck NeoplasmBiological Signal TransductionImmunocytochemistryBreast NeoplasmsHuman TissueHuman SubjectNeoplasm /Cancer EpidemiologyNeoplasm /Cancer GeneticsPatient Oriented ResearchBehavioral /Social Science Research TagSquamous Cell CarcinomaDna RepairGene Environment InteractionGenetic PolymorphismGenetic SusceptibilityHealth BehaviorHispanic AmericansHuman Papillomavirus
Grant awards (4)
ABERRANT SIGNAL TRANSDUCTION PATHWAYS AS CANCER MARKERS$0
P20 · FY2002 · CA
Epidemiologic, molecular and clinical determinants of head and neck cancer$0
U54 · FY2002 · CA
ABERRANT SIGNAL TRANSDUCTION PATHWAYS AS CANCER MARKERS$0
P20 · FY2001 · CA
ROLE OF TOPOISOMERASE II IN NBQ MEDIATED TUMOR CELL DIFFERENTIATION$120,680
S06 · FY2000 · GM